230 related articles for article (PubMed ID: 31839342)
21. Racial and ethnic disparities in the overall survival of women with epithelial ovarian cancer in Florida, 2001-2015.
Westrick A; Schlumbrecht M; Hlaing WM; Kobetz EK; Feaster D; Balise R
Cancer Causes Control; 2020 Apr; 31(4):333-340. PubMed ID: 32052218
[TBL] [Abstract][Full Text] [Related]
22. The elevated risk of ovarian clear cell carcinoma among Asian Pacific Islander women in the United States is not affected by birthplace.
Korenaga TR; Ward KK; Saenz C; McHale MT; Plaxe S
Gynecol Oncol; 2020 Apr; 157(1):62-66. PubMed ID: 32008796
[TBL] [Abstract][Full Text] [Related]
23. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
[TBL] [Abstract][Full Text] [Related]
24. A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy.
Zhao L; Yu P; Zhang L
Cancer Med; 2021 Jul; 10(13):4344-4355. PubMed ID: 34057318
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
27. Disparities in care among patients with low-grade serous ovarian carcinoma.
Siemon J; Galli J; Slomovitz B; Schlumbrecht M
Gynecol Oncol; 2020 Apr; 157(1):46-54. PubMed ID: 32008792
[TBL] [Abstract][Full Text] [Related]
28. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.
Kim S; Dolecek TA; Davis FG
Soc Sci Med; 2010 Jul; 71(2):274-281. PubMed ID: 20483517
[TBL] [Abstract][Full Text] [Related]
29. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
30. Epithelial ovarian cancer mortality among Hispanic women: Sub-ethnic disparities and survival trend across time: An analysis of SEER 1992-2013.
Chen C; Markossian TW; Silva A; Tarasenko YN
Cancer Epidemiol; 2018 Feb; 52():134-141. PubMed ID: 29306788
[TBL] [Abstract][Full Text] [Related]
31. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
32. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
33. Long-term mortality among women with epithelial ovarian cancer.
Dinkelspiel HE; Champer M; Hou J; Tergas A; Burke WM; Huang Y; Neugut AI; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2015 Aug; 138(2):421-8. PubMed ID: 26050923
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
[TBL] [Abstract][Full Text] [Related]
35. Disparities in treatment and survival among elderly ovarian cancer patients.
Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
[TBL] [Abstract][Full Text] [Related]
36. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
37. Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes.
Knisely A; Huang Y; Melamed A; Tergas AI; St Clair CM; Hou JY; Khoury-Collado F; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2020 Aug; 158(2):415-423. PubMed ID: 32456990
[TBL] [Abstract][Full Text] [Related]
38. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
39. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
[TBL] [Abstract][Full Text] [Related]
40. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]